Month: December 2012

Comparing Different Methods for Measuring Benefits for Economic Evaluation

Sheffield, UK – A comparison of the benefits and costs of different treatments for various patient groups to inform resource allocation decisions requires a comparable measure of benefit.

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , , , ,

Innovative Methods Uncover Differential Responders To Treatment

Manchester, UK – Variability in response to treatment (also called heterogeneity of treatment effects) is a common finding in clinical trials. Some variability is hypothesised and expected, such as differences between treatment and placebo groups, across doses, or between comparator drugs.

Posted in Methodological Articles, Value in Health Tagged with: , , , ,

Having Diabetes Mellitus May Cost The Patient 11.1 Years Of Healthy Life

New York, NY, USA – An 18-year old diabetic person is expected to live an additional 43.4 years of healthy life-11.1 years less than a non-diabetic person of the same age-according to a study by Columbia University in New York, NY

Posted in Health Policy Analyses, Value in Health Tagged with: , , , , , ,